Why is Novartis stock trading higher in premarket today

  • Novartis Corporation (NYSE: NVS) shares are trading higher in the previous marketing session after breast cancer drugs showed clinical benefit in early-stage breast cancer.

  • Novartis announces topline result from a prospective analysis of the Phase 3 NTALEE trial evaluating Kisqali (ribociclib) plus endocrine therapy (ET) in a broad population of patients with hormone/receptor-positive early breast cancer. Human epidermal growth factor 2 negative (HR+/HER2-) carries a risk of recurrence.

  • The independent data monitoring committee recommended stopping the trial early because the primary endpoint of invasive disease-free survival (iDFS) was met.

  • Kisqali plus ET significantly reduces the risk of disease recurrence, compared with standard adjuvant endocrine therapy alone, with consistent benefit in patients with stage II and stage III EBC regardless of involvement. of the ganglia.

  • According to the NATALE protocol, patient follow-up will continue to assess long-term outcomes, including overall survival.

  • Verzenio’s rival drug Eli Lilly And She (NYSE: LLY) was approved in the early stages for women at high risk of recurrence after surgery.

  • “Everything else being equal in terms of efficacy, it is anticipated that Kisqali can beat Verzenio by providing a more convenient side-effect profile,” Reuters notequote suffocating analyst Eric Le Berrigaud.

  • He added that the test update will boost low market confidence towards the targets set forth by CEO Vas Narasimhan for annual revenue growth of 4% through 2027 and profit margins. Core operating profit is 40% from 2027.

  • In 2022, Kisqali generated $1.23 billion in revenue, up 31% over the same period.

  • Price action: NVS stock was up 6.59% at $89.10 in the premarket session on Monday’s final test.

Don’t miss real-time alerts on your stocks – join Benzinga Pro free of charge! Try the tool that helps you invest smarter, faster and more efficiently.

this paragraph Why is Novartis stock trading higher in premarket today originally appeared on


© 2023 Benzinga does not provide investment advice. Copyright Registered.


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button